MedPath

Bariatric and Obstructive Lung Disease Study II

Terminated
Conditions
Obesity
Asthma
Registration Number
NCT01127399
Lead Sponsor
Johns Hopkins University
Brief Summary

The prevalence of obesity and asthma has significantly increased over the past two decades. The purpose of this study is to try and understand the mechanism by which obesity leads to airway hyperresponsiveness (AHR), one of the defining features of asthma. This research is being done to determine how weight or body size affects airway size and airway smooth muscle (ASM) tone and function. The goal of the study will be to look at if and how, weight might affect lung functioning.

The investigators hypothesize that low lung volumes in obesity lead to AHR by reducing airway caliber causing increased ASM tone with impairment in deep inspiration (DI) response similar to what is seen in asthma.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age 18 years or older
  • BMI over 35 kg/m2 (Bariatric) or BMI between 25 and 28 kg/m2 (Control)
  • Physician diagnosis of asthma and on active asthma medication (if asthmatic)
Exclusion Criteria
  • Weight greater than 450 lbs
  • Unstable cardiovascular disease
  • Uncontrolled hypertension
  • Renal failure on dialysis
  • Cirrhosis
  • Pregnant or lactating
  • Bleeding disorders or Coumadin use
  • Recent hospitalization for asthma in the past 3 months
  • Active smoking or more than 10 pack year smoking history

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Johns Hopkins University, The Johns Hopkins Bayview Medical Campus

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Β© Copyright 2025. All Rights Reserved by MedPath